Keyphrases
Neurokinin B
100%
NF-B
100%
Substance P
100%
Pathophysiology
100%
Mood Disorders
100%
Inflammatory Markers
100%
Implications for Treatment
100%
Vortioxetine
100%
Inflammation
50%
Antidepressants
50%
Monocytes
50%
Human Monocytes
50%
Interleukin-6
50%
Response to Treatment
50%
Cytokine Production
50%
Interleukin-4 (IL-4)
50%
Major Depressive Disorder
50%
Psychiatric Disorders
50%
Brain Regions
50%
Gene Expression
50%
C-reactive Protein
50%
Oxyradicals
50%
Serum Levels
50%
Interleukin-1β
50%
Anti-inflammatory Effect
50%
Bipolar Disorder
50%
Disease-specific
50%
Tumor Necrosis Factor-α
50%
Innate Immune Response
50%
Inflammatory Cytokines
50%
Healthy Donors
50%
Disability
50%
M2 Macrophages
50%
Interleukin
50%
Microglial Activation
50%
Serotoninergic Agents
50%
All-phase
50%
TNF Receptor 1 (TNFR1)
50%
TNF Gene
50%
Psycho
50%
Chronic Disorders
50%
M1 Macrophages
50%
Neuroimmunomodulation
50%
Soluble Receptor
50%
Medication Effects
50%
PPAR Gene
50%
Immunomodulatory Action
50%
Neuroimmunology
50%
Neuroscience
Neurokinin
100%
Substance P
100%
Mood Disorder
100%
Vortioxetine
100%
Antidepressant
50%
Major Depressive Disorder
50%
Gene Expression
50%
Interleukin 6
50%
Proinflammatory Cytokine
50%
Bipolar Disorder
50%
Tumor Necrosis Factor Alpha
50%
Macrophage
50%
Psychoactive Drug
50%
Anti-Inflammatory
50%
Cytokine Production
50%
Interleukin 4
50%
Peroxisome Proliferator-Activated Receptor
50%
Interleukin
50%
C-Reactive Protein
50%
Receptor
50%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Necrosis Factor
100%
Pathophysiology
100%
Mood Disorder
100%
Disease
80%
Cytokine
80%
Substance P
40%
Neurokinin
40%
Vortioxetine
40%
Receptor
20%
Antidepressant
20%
C Reactive Protein
20%
Peroxisome Proliferator Activated Receptor
20%
Inflammation
20%
Interleukin 6
20%
Bipolar Disorder
20%
Psychotropic Agent
20%
Antiinflammatory Activity
20%
Immunomodulation
20%
Interleukin 4
20%
Major Depression
20%